News
TECH
72.29
+0.54%
0.39
Bio-Techne (TECH) Stock Could Be 21% Above Fair Value On Earnings And Cash Flow
Simply Wall St · 1h ago
JAZZ vs. TECH: Which Stock Is the Better Value Option?
NASDAQ · 1d ago
Charles River Laboratories International Inc. Stock Advances 11.4%, Outperforms Peers
Dow Jones · 2d ago
Can These 3 MedTech Stocks Hit Targets This Earnings Season?
NASDAQ · 3d ago
Weekly Report: what happened at TECH last week (0727-0731)?
Weekly Report · 4d ago
Madison Mid Cap Fund Q2 2026 Portfolio Activity
Seeking Alpha · 07/31 13:49
Conestoga SMid Cap Composite Q2 2026 Portfolio Review
Seeking Alpha · 07/31 12:38
RSP, TECH, PYPL, CRL: ETF Inflow Alert
NASDAQ · 07/30 15:20
Charles River Laboratories International Inc. Stock Rises 7.2%, Outperforms Peers
Dow Jones · 07/28 20:34
Incyte Corp. Stock Advances 9.3%, Outperforms Peers
Dow Jones · 07/28 20:33
Cognizant launches EMEA AI Unit to scale agentic AI adoption across Europe, Middle East, Africa
PUBT · 07/28 09:01
Most S&P 500 stocks trade above 50-day moving average for first time since February
Seeking Alpha · 07/28 08:41
Weekly Report: what happened at TECH last week (0720-0724)?
Weekly Report · 07/27 09:38
Bio-Techne (TECH) Stock Looks Fully Priced On Cash Flow And Earnings
Simply Wall St · 07/26 18:16
Financials, tech and healthcare lead list of overbought large caps
Seeking Alpha · 07/24 14:21
Charles River Laboratories International Inc. Stock Advances 4.8%, Outperforms Peers
Dow Jones · 07/23 20:35
Biotech stocks lead healthcare's overbought list as earnings picks up
Seeking Alpha · 07/23 11:18
Noteworthy ETF Outflows: RSP, MRNA, TECH, GPC
NASDAQ · 07/22 14:48
Sequoia Strategy trims Sunbelt, Elevance; exits Liberty Broadband
Seeking Alpha · 07/20 14:48
Weekly Report: what happened at TECH last week (0713-0717)?
Weekly Report · 07/20 09:36
More
Webull provides a variety of real-time TECH stock news. You can receive the latest news about Bio-Techne Corp through multiple platforms. This information may help you make smarter investment decisions.
About TECH
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.